Crazy! Blew $26 billion in a single quarter—Saudi Sovereign Wealth Fund bet 70% of its portfolio on Musk? **Sell-offs** 1. **Allurion Technologies Warrants (ALUR)** Core product: Allurion Balloon, the world’s only swallowable, non-surgical gastric balloon. Paired with AI remote monitoring, it helps overweight and obese patients lose 10-15% of their weight in about 16 weeks. Fully exited related warrants to further focus on core long-term strategic assets and reduce exposure to non-core businesses. **Buys** 2. **SpaceX (SPCX)** New position: ~154.1 million shares, valued at ~$26.34 billion, making up nearly 70% of the disclosed U.S. stock portfolio. As a global leader in commercial spaceflight, SpaceX holds unique monopolistic advantages in reusable rocket technology and the Starlink satellite internet network. Huge growth potential in low-orbit communications, space transportation, and the future space economy, perfectly aligned with Saudi Arabia’s diversification strategy. 3. **Uber (UBER)** No change in holdings: ~72.84 million shares, valued at ~$5.26 billion. Uber boasts strong network effects and scale advantages in global mobility and delivery, with continuous platform expansion and significantly improved profitability. High certainty for long-term growth. 4. **Electronic Arts (EA)** No change in holdings: ~24.81 million shares, valued at ~$5.09 billion. EA is a top-tier global game publisher with iconic IPs like FIFA and Battlefield. Its content ecosystem is solid, with strong growth potential in subscriptions and live services, and robust cash flow. 5. **Lucid (LCID)** No change in holdings: ~177.1 million shares, valued at ~$1.18 billion. As a premium EV brand, Lucid leads in technology and has deep collaboration with Saudi Arabia. It benefits from the global electrification trend and localized production layout, making it a standout long-term strategic asset. 6. **Clarivate (CTEV)** No change in holdings: ~1.28 million shares, valued at ~$43.7 million. A medical data and management services company with stable operations and niche advantages in the healthcare IT sector. Retained as a defensive allocation within the portfolio. **Heavy bets to the moon! **